Updated October 15, 2021
Note: This situation is continuously evolving; please subscribe to the Communiqué e-newsletter to receive regular updates.
For all symptoms, including atypical symptoms, which should be considered particularly in children, older persons, and people living with a developmental disability, see the Ontario Ministry of Health’s COVID-19 Reference Document for Symptoms.
See the Government of Ontario’s Current Case Definition for COVID-19.
Toronto Public Health continues to actively monitor the situation in collaboration with provincial and national health agencies and stakeholders that include local hospitals, airports and community agencies.
Up-to-date information regarding:
Health care settings are being requested to conduct passive and active screening of anyone entering the premises, as detailed by the Ontario Ministry of Health’s COVID-19 Patient Screening Guidance Document.
If this document does not contain information specific to your healthcare setting, please see other documents in the Ontario Ministry of Health’s Health Sector Resources
For guidance about testing:
If your healthcare setting conducts COVID-19 tests onsite, please review the following guidance to ensure that samples are collected and handled properly:
To get tested for COVID-19 in the City of Toronto, please visit the Toronto COVID-19 Testing website.
To get tested for COVID-19 in another region, please visit the Ontario COVID-19 testing locations website.
The following may be used to obtain COVID-19 test results:
Health Canada has authorized Pfizer-BioNTech, Moderna, AstraZeneca, and Janssen (Johnson & Johnson) COVID-19 vaccines. At this time the Janssen product is not available in Ontario, and the administration of any additional first doses of the AstraZeneca/COVISHIELD COVID-19 vaccines has been paused.
Everyone living in Toronto who is able to get the vaccine should be vaccinated when it is their turn. Vaccines can provide protection from variant strains, and are still recommended to those who have had COVID-19 in the past.
Find more information on eligibility and booking COVID-19 vaccine appointments.
All Toronto primary care providers and general pediatricians are invited to administer COVID-19 vaccines in their offices. Eligibility criteria are listed on the Eligibility Criteria for Ordering Vaccine from Toronto Public Health website.
To order Pfizer-BioNTech and Moderna COVID-19 vaccines, complete the TPH COVID-19 Vaccine Program Enrollment Request Form and the onboarding process. Please only complete this form once for each primary care or general pediatric practice. Once complete, access to the ordering portal will be provided.
Email questions about enrolling in the Toronto Primary Care COVID-19 Vaccine Program to COVIDVaccineOrder@toronto.ca.
Physicians with questions pertaining to the submission of these billing codes should email the ministry’s Service Support Contact Centre at SSContactCentre.MOH@ontario.ca
Everyone born in 2009 and earlier is eligible to book second doses of COVID-19 vaccine per the product monograph intervals:
AstraZeneca COVID-19 vaccine is available at a City-run immunization clinic for those that are unable to receive mRNA vaccines (Pfizer-BioNTech or Moderna) by referral only.
Refer eligible patients by completing TPH’s AstraZeneca COVID-19 Vaccine Referral Form and providing this form to the patient for presentation at the immunization clinic. Patients must bring this referral form in order to receive their immunization.
For the general population, two doses of the COVID-19 vaccines provides strong protection against severe illness and hospitalization. This includes protection against the Delta variant of concern. Research shows that certain people with low immune response can benefit from a third dose.
A third dose can be given at a minimum of two months (8 weeks) after the second dose for:
*Active treatment includes people who have completed treatment within three months. Active treatment is defined as chemotherapy, targeted therapies, immunotherapy, and excludes people receiving therapy that does not suppress the immune system (e.g. solely hormonal therapy or radiation therapy).
**Active treatment for people receiving B-cell depleting therapy including people who have completed treatment within 12 months.
Patients on immunosuppressive treatment should discuss the optimal timing of all vaccine doses with their health care provider. If readily available, the same mRNA vaccine product should be provided for third doses.
For more information on timing of COVID-19 vaccine, see the National Comprehensive Cancer Network’s Recommendations of the National Comprehensive Cancer Network® (NCCN®) COVID-19 Vaccination Advisory Committee
*If you prefer to provide the patient with a referral letter instead of completing the third dose patient referral form, please include the following information
It is recommended that residents of long-term care homes, retirement homes and elder care lodges receive a booster dose of vaccine at a minimum of five months (20 weeks) after their second dose. On October 7, 2021 the Ministry of Health expanded the list to include elderly living in other congregate settings (e.g. assisted-living facilities, chronic care hospitals, naturally occurring congregate retirement settings/congregate senior’s apartment buildings, etc.) The Ministry is continuing to draft a list of congregate care locations that should be the focus of this expanded eligibility. More information will be shared as soon as it is available.
The Ministry of Health has published guidance to assist health care providers evaluate contraindications or precautions to COVID-19 vaccination that may warrant a medical exemption. Refer to Table 1 for details.
True medical exemptions are expected to be infrequent and should be supported by expert consultation. Referral and specialist consultation support for physicians and nurse practitioners is available through Ontario’s eConsult Service, OTN Hub, and the Special Immunization Clinic (SIC) Network. In many instances, safe administration of subsequent doses of COVID-19 vaccine is possible under the management of an allergist/immunologist.
Providers may be asked to provide a statement of medical exemption for their patients, and if they are eligible, providers may use the Ministry’s Sample Statement of Medical Exemption.
Do not administer vaccine to clients without an allergist consult if they have a history of:
An AEFI is an unwanted or unexpected health effect that happens after someone receives a vaccine, which may or may not be caused by the vaccine. Of particular interest are unusual or unexpected events, or serious reactions requiring urgent care.
Adverse Event or Safety Signal Description
Follow Up and Counseling
|Moderna||Delayed Local Reactions
|AstraZeneca / COVISHIELD||Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
|Pfizer-BioNTech and Moderna||Myocarditis/Pericarditis
The COVID-19 vaccine is the best way to protect your health care setting from the risks of COVID-19. Mangers and clinicians can help encourage vaccination among staff by creating a supportive environment that makes it easier for everyone to get vaccinated.
Please note: the information provided on this webpage does not contain legal advice and should not be relied on or treated as legal advice; those for whom these recommendations are intended may seek their own legal advice for their specific circumstance.
COVID-19 outbreaks in institutional facilities are reportable to their local public health unit. Long-term care homes are also required to report COVID-19 outbreaks to the Ministry of Long-Term Care (MOLTC).
While we aim to provide fully accessible content, there is no text alternative available for some of the content on this site. If you require alternate formats or need assistance understanding our maps, drawings, or any other content, please contact us at LRCT@toronto.ca.
There are no specific treatments for coronaviruses. Most people with common human coronavirus illness will recover on their own.
Probable and confirmed cases of COVID-19 must be immediately reported to Toronto Public Health by telephone at 416-392-7411 (after hours: 311), or by faxing TPH’s COVID-19 Reporting Form to 416-696-3477.